Boston Scientific Corp
DUS:BSX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Boston Scientific Corp
DUS:BSX
|
US |
|
G
|
Gilead Sciences, Inc
XMUN:GIS
|
US |
|
B
|
Boston Scientific Corp
F:BSX
|
US |
|
B
|
Boston Scientific Corp
XMUN:BSX
|
US |
|
H
|
Halma PLC
OTC:HALMY
|
UK |
Intrinsic Value
Is BSX undervalued or overvalued?
See the intrinsic value estimate for 
Boston Scientific Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Boston Scientific Does
Boston Scientific makes medical devices that doctors use to diagnose and treat problems inside the body. Its products include tools for heart care, rhythm management, digestive health, urology, and other minimally invasive procedures. Hospitals, clinics, and specialist doctors buy these devices because they help treat patients without major surgery.
- Headquarters
- United States of America US
- Employees
- 59 000
- IPO date
- May 19, 1992
Boston Scientific has a narrow economic moat
Protected device designs and the time needed to win medical approvals make Boston Scientific’s products difficult to copy. Hospitals also invest in compatible equipment and staff training, making a move to another supplier more work than simply choosing a cheaper device. These barriers protect parts of its business rather than keeping competitors out altogether.
Read the full moat analysis
Revenue & Expenses Breakdown
Boston Scientific Corp
Earnings Waterfall
Boston Scientific Corp
The intrinsic value for Boston Scientific Corp (BSX) under the Base Case is hidden EUR.
Compared with the current market price of 39.095 EUR, the stock appears hidden.
